The Broad Reach Of New 'Failure-To-Warn-FDA' Claims

Law360, New York (January 23, 2013, 1:25 PM EST) -- Recently, the Ninth Circuit created a new state-law cause of action against medical device manufacturers: "failure to warn the U.S. Food and Drug Administration." The en banc opinion in Stengel v. Medtronic Inc., __ F.3d __, 13 C.D.O.S. 365 (9th Cir. 2013), delivered by Judge William Fletcher, held that the Medical Device Amendments (MDA) to the Food, Drug and Cosmetic Act (FDCA) did not preempt this claim because it paralleled a federal law duty imposed by the MDA....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!